Literature DB >> 14747943

Characterisation of a beta-tubulin gene from the monogenean parasite, Gyrodactylus salaris Malmberg, 1957.

C M Collins1, K A Miller, C O Cunningham.   

Abstract

The cDNA and two partial genomic sequences of beta-tubulin genes have been isolated from the monogenean parasite Gyrodactylus salaris. The cDNA sequence is not represented by either of the genomic sequences, implying that at least three isotypes of the gene exist in G. salaris. The sequences show regions of high homology with other helminth beta-tubulin genes. This represents the first isolation of a beta-tubulin gene from a monogenean and contributes to the overall characterisation of these genes within the helminths. This is an important area, as anthelmintic resistance is increasing against benzimidazole drugs that target the beta-tubulin gene. Benzimidazole drugs have been tested successfully against Gyrodactylus parasites, but their use is not widespread. Should it increase, analysis of the beta-tubulin gene may provide a tool for monitoring resistance development and improving management practises. Use of the beta-tubulin gene in the identification of Gyrodactylus species may prove complex due to the presence of different isotypes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14747943     DOI: 10.1007/s00436-003-1028-x

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  27 in total

1.  Anthelmintic resistance and parasite control in commercial eel farms: consequences for producers.

Authors:  P J Waller; K Buchmann
Journal:  Vet Rec       Date:  2001-06-23       Impact factor: 2.695

2.  Amino acid alterations in the benA (beta-tubulin) gene of Aspergillus nidulans that confer benomyl resistance.

Authors:  M K Jung; I B Wilder; B R Oakley
Journal:  Cell Motil Cytoskeleton       Date:  1992

Review 3.  The role of the cytoskeletal protein, tubulin, in the mode of action and mechanism of drug resistance to benzimidazoles.

Authors:  E Lacey
Journal:  Int J Parasitol       Date:  1988-11       Impact factor: 3.981

4.  Cloning and characterization of cDNAs encoding beta-tubulin from Dirofilaria immitis and Onchocerca volvulus.

Authors:  T G Geary; S C Nulf; S J Alexander-Bowman; B M Mahmoud; R K Prichard; R D Klein
Journal:  J Parasitol       Date:  1998-04       Impact factor: 1.276

5.  Benzimidazole resistance in Haemonchus contortus is correlated with a conserved mutation at amino acid 200 in beta-tubulin isotype 1.

Authors:  M S Kwa; J G Veenstra; M H Roos
Journal:  Mol Biochem Parasitol       Date:  1994-02       Impact factor: 1.759

6.  Redescription of Gyrodactylus teuchis Lautraite, Blanc, Thiery, Daniel & Vigneulle, 1999 (Monogenea: Gyrodactylidae); a species identified by ribosomal RNA sequence.

Authors:  C O Cunningham; T A Mo; C M Collins; K Buchmann; R Thiery; G Blanc; A Lautraite
Journal:  Syst Parasitol       Date:  2001-02       Impact factor: 1.431

7.  Molecular characterisation of beta-tubulin genes present in benzimidazole-resistant populations of Haemonchus contortus.

Authors:  M S Kwa; J G Veenstra; M H Roos
Journal:  Mol Biochem Parasitol       Date:  1993-07       Impact factor: 1.759

8.  Haemonchus contortus: the role of two beta-tubulin gene subfamilies in the resistance to benzimidazole anthelmintics.

Authors:  G W Lubega; R D Klein; T G Geary; R K Prichard
Journal:  Biochem Pharmacol       Date:  1994-04-29       Impact factor: 5.858

9.  Discrimination between Gyrodactylus salaris, G. derjavini and G. truttae (Platyhelminthes: Monogenea) using restriction fragment length polymorphisms and an oligonucleotide probe within the small subunit ribosomal RNA gene.

Authors:  C O Cunningham; D M McGillivray; K MacKenzie; W T Melvin
Journal:  Parasitology       Date:  1995-07       Impact factor: 3.234

10.  Genetic and molecular analysis of a Caenorhabditis elegans beta-tubulin that conveys benzimidazole sensitivity.

Authors:  M Driscoll; E Dean; E Reilly; E Bergholz; M Chalfie
Journal:  J Cell Biol       Date:  1989-12       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.